Pet medicine report lookup / Oclacitinib / Cats

What has been reported to the FDA for Oclacitinib in cats?

Short answer: The FDA has received 463 adverse event reports for cats that name Oclacitinib. No FDA-approved animal drug containing Oclacitinib was found for cats. The FDA lists approved products for dog. These are counts of reports, not a rate of side effects.
Report counts read · approval records read
Veterinary disclosure Not veterinary advice. A report to the FDA is a suspicion, not proof that a medicine caused an event, and nothing here measures how often a side effect happens. Do not start, stop or change a medicine because of this page. Talk to a licensed veterinarian who knows your animal.
Oclacitinibin cats
463reports to the FDA

The FDA has received 463 adverse event reports for cats that name Oclacitinib.

  1. 463 reports name Oclacitinib in cats, which is 0.3% of all 151,164 cat reports. A report counts under every active ingredient it names.
  2. 51% are marked serious and 16% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
  3. 22% are complaints that the product did not work (19% across all cat reports).
  4. The clinical signs reported most are accidental exposure, vomiting and lack of efficacy.
  5. No FDA-approved animal drug containing Oclacitinib was found for cats. The FDA lists approved products for dog.
  6. None of this is a rate. The FDA data does not record how many cats were given Oclacitinib, so it cannot say how often any of this happens.

How the reports break down

What the reports sayReportsShare of this medicine's reportsAll cat reports
Marked seriousthe FDA record flags the report as serious23451%27%
Death or euthanasiathe outcome recorded in the report, with no finding of cause7316%9.4%
Did not worka complaint that the product failed to work, which the FDA files as an adverse event10222%19%
Seizurea seizure or convulsion is among the clinical signs40.9%2.6%
Not used per labelthe report says the product was not used the way its label directs44295%33%

Where on the body do the reported signs sit?

22%21%

Not on the body: How it was given 28% Whole body 16% Did not work 8.8%

  1. How it was given28%accidental exposure, overdose, intentional misuse, medication error
  2. Stomach and gut22%vomiting, diarrhoea, not eating, weight loss and 2 more
  3. Blood and organ tests21%elevated alanine aminotransferase (alt), azotaemia, elevated blood urea nitrogen (bun), elevated creatinine and 4 more
  4. Whole body16%lethargy, death by euthanasia, death, lethargy
  5. Did not work8.8%lack of efficacy, ineffective, atopy control
  6. Eyes3.0%third eyelid protrusion

Each figure is a share of sign mentions among the 25 signs reported most for Oclacitinib in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.

Clinical signs reported most

  1. Accidental exposure123 27%
  2. Vomiting81 17%
  3. Lack of efficacy66 14%
  4. Lethargy66 14%
  5. Overdose56 12%
  6. Intentional misuse54 12%
  7. Medication error50 11%
  8. Elevated alanine aminotransferase (ALT)45 9.7%

Reports received per year

12302014: 5 reports2015: 13 reports2016: 18 reports2017: 21 reports2018: 40 reports2019: 13 reports2020: 24 reports2021: 20 reports2022: 12 reports2023: 35 reports2024: 79 reports2025: 123 reports2026: 60 reports2014201620182020202220242026
More reports in a year can mean more animals treated, a newer product under closer watch, or more people reporting. 2026 is a part year. The tallest bar is 123 reports (2025).

Is it approved for cats?

DogsFDA-approved product listed
Catsno approved product found
Other animalsnone found
No approval found for cats

No FDA-approved animal drug containing Oclacitinib was found for cats. The FDA lists approved products for dog.

Reports for cats exist even though no approved product for cats was found. Veterinarians may lawfully prescribe some medicines outside their label, and a report records what was given, not what was approved.

What can you do next?

What it cost in our price study$124 to $178 at a vet officeApoquel (oclacitinib), 16 mg tablet. The same study recorded $98 at Chewy and $108 at PetMeds. Prices collected April to May 2026; quantity and method are in the study.
Seen a side effect yourself?Report itCall your veterinarian first if your animal is unwell. Then report to the drug maker or to the FDA: the FDA explains both routes. Reports like yours are what this page counts.

Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.

Where can you go from this result?

This result is one of 94 in the lookup. See Oclacitinib in dogs (28,973 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.

To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.

Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.

☆ Save